Fulgent Genetics Inc (FLGT) — Capital Reinvestment Ratio
Latest as of March 2026:
0.73x
Fulgent Genetics Inc (FLGT) has a Capital Reinvestment Ratio of 0.73x as of March 2026, meaning it reinvests 1% of its operating cash flow ($7.10 Million) in capital expenditures ($5.20 Million). See FLGT free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.73x
Capex / Operating Cash Flow
Operating Cash Flow
$7.10 Million
USD
Capital Expenditures
$5.20 Million
USD
Data as of
Mar 2026
Most recent filing
Fulgent Genetics Inc Capital Reinvestment Ratio (2016–2024)
This chart tracks Fulgent Genetics Inc's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Fulgent Genetics Inc (2016–2024)
Year-by-year Capital Reinvestment Ratio for Fulgent Genetics Inc from 2016 to 2024. For live market cap and broader valuation context, see FLGT company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.91x | $21.06 Million | $40.31 Million | ▲ +132.8% |
| 2023 | 0.82x | $27.00 Million | $22.21 Million | ▲ +1010.5% |
| 2022 | 0.07x | $253.52 Million | $18.77 Million | ▲ +67.3% |
| 2021 | 0.04x | $538.58 Million | $23.84 Million | ▼ -82.9% |
| 2020 | 0.26x | $140.63 Million | $36.51 Million | ▲ +21.2% |
| 2019 | 0.21x | $5.52 Million | $1.18 Million | ▼ -94.7% |
| 2017 | 4.02x | $1.33 Million | $5.36 Million | ▲ +367.9% |
| 2016 | 0.86x | $4.41 Million | $3.79 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow